3 withdrawn, 1 terminated. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Withdrawn 3, Terminated 1 |
| Phase 2 | 2 | Withdrawn 2 |
Follow ADV7103: new trials by email Literature Review of ADV7103 trials Research Report on ADV7103
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating Patients With Cystinuria ADV7103, Standard of Care - Cystinuria | Phase 2 / Phase 3 | Withdrawn | Advicenne Pharma | 2024-05-01 | 2024-03-12 | |
| Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children ADV7103, Placebo - Cystinuria | Phase 2 / Phase 3 | Withdrawn | Advicenne Pharma | 2024-03-01 | 2026-01-08 | |
| Extension Study in Primary Distal Renal Tubular Acidosis ADV7103 - Acidosis, Renal Tubular | Phase 3 | Withdrawn | Advicenne Pharma | 2023-12-20 | 2026-02-09 | |
| Study Evaluating Subjects With Distal Renal Tubular Acidosis ADV7103, Placebo - Distal Renal Tubular Acidosis | Phase 3 | Terminated | Advicenne Pharma | 3 | 2021-09-20 | 2026-06-03 |
Acidosis, Renal Tubular (2) · Cystinuria (2)
Advicenne Pharma (4)
Belgium (2) · France (2) · United States (2) · Canada (1)
Andre Ulmann, M.D., Ph.D. (1) · Laurence Greenbaum, MD, Ph.D. (1)